Binghamton Researcher Awarded $2.75M Grant to Develop Next-gen Cancer Treatments
April 24, 2026
April 24, 2026
BINGHAMTON, New York, April 24 -- Binghamton University issued the following news:
* * *
Binghamton researcher awarded $2.75M grant to develop next-gen cancer treatments
Pharmacy faculty works to develop antibody-drug-conjugate technology
By Ethan Knox '20
A leading expert in antibody-drug-conjugate (ADC) technology, L. Nathan Tumey has worked for nearly two decades developing new approaches for the treatment of cancer. Now, t . . .
* * *
Binghamton researcher awarded $2.75M grant to develop next-gen cancer treatments
Pharmacy faculty works to develop antibody-drug-conjugate technology
By Ethan Knox '20
A leading expert in antibody-drug-conjugate (ADC) technology, L. Nathan Tumey has worked for nearly two decades developing new approaches for the treatment of cancer. Now, t . . .